C
Blood viscosity
Hemostatic & ThromboticLab test / biomarkerriskpartially modifiable
8
evidence score
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 3meta-analyses: 0trials: 4.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Lipoprotein apheresis. — Cardiology clinics 2015 · PMID 25939293
Clinical trials (2)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT05730621 | A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease; A Prospective, Randomized, Parallel, Open-Label, Single-center, Phase IV Clinical Trial | COMPLETED | INTERVENTIONAL | Sarpogrelate Sustained Release/Aspirin, Aspirin |
| NCT01758874 | Phase 2 Study to Explore the Effect of Lowering Blood Viscosity in Patients With Treatment-resistant Critical Limb Ischemia | COMPLETED | INTERVENTIONAL | phlebotomy |
Genetic associations (0)
None linked.